Kendall A. Marcus

749 total citations
17 papers, 585 citations indexed

About

Kendall A. Marcus is a scholar working on Epidemiology, Infectious Diseases and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kendall A. Marcus has authored 17 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Infectious Diseases and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kendall A. Marcus's work include Neuroscience and Neuropharmacology Research (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and HIV-related health complications and treatments (4 papers). Kendall A. Marcus is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and HIV-related health complications and treatments (4 papers). Kendall A. Marcus collaborates with scholars based in United States, Denmark and United Kingdom. Kendall A. Marcus's co-authors include Peter J. Whitehouse, Kenneth J. Kellar, Donald L. Price, Peter Miele, Xiao Ding, Cynthia Kornegay, Mat Soukup, Charles K. Cooper, Annamaria Martino and Harvey S. Singer and has published in prestigious journals such as Neurology, Clinical Infectious Diseases and Brain Research.

In The Last Decade

Kendall A. Marcus

16 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kendall A. Marcus United States 11 213 157 142 132 109 17 585
Curtis Vande Stouwe United States 16 155 0.7× 83 0.5× 113 0.8× 65 0.5× 164 1.5× 22 626
N. Ueda Japan 13 101 0.5× 228 1.5× 32 0.2× 87 0.7× 101 0.9× 23 722
Kalyan Ghosh United States 8 226 1.1× 285 1.8× 25 0.2× 157 1.2× 90 0.8× 8 804
Kathy Conant United States 7 179 0.8× 259 1.6× 224 1.6× 50 0.4× 539 4.9× 8 785
A. R. Guimaraes Brazil 11 94 0.4× 62 0.4× 67 0.5× 35 0.3× 121 1.1× 17 488
Linda Gelgor Australia 15 155 0.7× 88 0.6× 19 0.1× 112 0.8× 164 1.5× 22 709
Paolo Baroldi Italy 12 49 0.2× 353 2.2× 58 0.4× 42 0.3× 262 2.4× 23 733
Stephen Ramage United Kingdom 5 69 0.3× 127 0.8× 130 0.9× 45 0.3× 329 3.0× 7 489
Antonia Wadley South Africa 15 37 0.2× 85 0.5× 69 0.5× 51 0.4× 161 1.5× 30 450
Jennifer Kelschenbach United States 13 149 0.7× 60 0.4× 48 0.3× 124 0.9× 261 2.4× 19 555

Countries citing papers authored by Kendall A. Marcus

Since Specialization
Citations

This map shows the geographic impact of Kendall A. Marcus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kendall A. Marcus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kendall A. Marcus more than expected).

Fields of papers citing papers by Kendall A. Marcus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kendall A. Marcus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kendall A. Marcus. The network helps show where Kendall A. Marcus may publish in the future.

Co-authorship network of co-authors of Kendall A. Marcus

This figure shows the co-authorship network connecting the top 25 collaborators of Kendall A. Marcus. A scholar is included among the top collaborators of Kendall A. Marcus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kendall A. Marcus. Kendall A. Marcus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Daniels, Selena, et al.. (2022). Measuring What Matters to Patients in Dermatology Drug Development. Dermatologic Clinics. 40(3). 333–337. 3 indexed citations
2.
Verma, Kapil, et al.. (2022). Food and Drug Administration perspective: Advancing product development for non‐healing chronic wounds. Wound Repair and Regeneration. 30(3). 299–302. 23 indexed citations
3.
Alavi, Afsáneh, April W. Armstrong, Amit Garg, et al.. (2021). International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting. Dermatology. 238(3). 430–437. 6 indexed citations
4.
5.
Lee, Jee Eun, et al.. (2019). Effect of Body Weight on Risk‐Benefit and Dosing Regimen Recommendation of Secukinumab for the Treatment of Moderate to Severe Plaque Psoriasis. Clinical Pharmacology & Therapeutics. 106(1). 78–80. 9 indexed citations
6.
Arya, Vikram, Jeffry Florian, Kendall A. Marcus, et al.. (2013). Does an Increase in Serum Creatinine always Reflect Renal Injury? The Case of Stribild®. The Journal of Clinical Pharmacology. 54(3). 279–281. 10 indexed citations
7.
Marcus, Kendall A., et al.. (2012). Current advances in pharmacovigilance in the USA and Europe. Current Opinion in HIV and AIDS. 7(4). 292–298. 10 indexed citations
8.
Ding, Xiao, Charles K. Cooper, Peter Miele, et al.. (2012). No Association of Abacavir Use With Myocardial Infarction. JAIDS Journal of Acquired Immune Deficiency Syndromes. 61(4). 441–447. 127 indexed citations
9.
Triant, Virginia A., Filip Josephson, Keri N. Althoff, et al.. (2011). Adverse Outcome Analyses of Observational Data: Assessing Cardiovascular Risk in HIV Disease. Clinical Infectious Diseases. 54(3). 408–413. 15 indexed citations
10.
Simpson, David M., Lydia Estanislao, Scott Evans, et al.. (2004). HIV-associated neuromuscular weakness syndrome. AIDS. 18(10). 1403–1412. 47 indexed citations
11.
Christiaans, Maarten H. L., Jip de Vries, Otto Bekers, et al.. (2004). MDR-1 AND CYP P450 GENE POLYMORPHISMS AND 12-HR AUC PHARMACOKINETICS OF TACROLIMUS.. Transplantation. 78. 455–455.
12.
Miele, Peter, Charles S. Levy, Steven Goldstein, et al.. (2001). Seven cases of surgical native valve endocarditis caused by coagulase-negative staphylococci: An underappreciated disease. American Heart Journal. 142(4). 571–576. 23 indexed citations
13.
Whitehouse, Peter J., Annamaria Martino, Kendall A. Marcus, et al.. (1988). Reductions in Acetylcholine and Nicotine Binding in Several Degenerative Diseases. Archives of Neurology. 45(7). 722–724. 102 indexed citations
14.
Kellar, Kenneth J., et al.. (1987). Muscarinic and nicotinic cholinergic binding sites in alzheimer's disease cerebral cortex. Brain Research. 436(1). 62–68. 124 indexed citations
15.
Bolger, Gordon T., et al.. (1987). Enhancement of [3H]DAGO1 binding to rat brain by low concentrations of monovalent cations. Canadian Journal of Physiology and Pharmacology. 65(11). 2338–2345. 3 indexed citations
16.
Trifiletti, R. R., Adele M. Snowman, Peter J. Whitehouse, Kendall A. Marcus, & S H Snyder. (1987). Huntington's disease. Neurology. 37(6). 916–916. 24 indexed citations
17.
Bolger, Gordon T., Kendall A. Marcus, John W. Daly, & P. Skolnick. (1987). Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.. Journal of Pharmacology and Experimental Therapeutics. 240(3). 922–930. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026